These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29895159)

  • 1. In search of effective H1N1 neuraminidase inhibitor by molecular docking, antiviral evaluation and membrane interaction studies using NMR.
    Malbari K; Gonsalves H; Chintakrindi A; Gohil D; Joshi M; Kothari S; Srivastava S; Chowdhary A; Kanyalkar M
    Acta Virol; 2018; 62(2):179-190. PubMed ID: 29895159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Novel Pyrazole Derivatives as Potent Neuraminidase Inhibitors against Influenza H1N1 Virus.
    Meng FJ; Sun T; Dong WZ; Li MH; Tuo ZZ
    Arch Pharm (Weinheim); 2016 Mar; 349(3):168-74. PubMed ID: 26797880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase.
    Li C; Fang JS; Lian WW; Pang XC; Liu AL; Du GH
    Chem Biol Drug Des; 2015 Apr; 85(4):427-38. PubMed ID: 25185493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and one-pot synthesis of 2-thiazolylhydrazone derivatives as influenza neuraminidase inhibitors.
    Yuan K; Xiao M; Tan Y; Ye J; Xie Y; Sun X; Hu A; Lian W; Liu A
    Mol Divers; 2017 Aug; 21(3):565-576. PubMed ID: 28536876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
    Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
    Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
    Neri-Bazán RM; García-Machorro J; Méndez-Luna D; Tolentino-López LE; Martínez-Ramos F; Padilla-Martínez II; Aguilar-Faisal L; Soriano-Ursúa MA; Trujillo-Ferrara JG; Fragoso-Vázquez MJ; Barrón BL; Correa-Basurto J
    Eur J Med Chem; 2017 Mar; 128():154-167. PubMed ID: 28182988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study.
    Cai Z; Zhang G; Tang B; Liu Y; Fu X; Zhang X
    Cell Biochem Biophys; 2015 Jul; 72(3):727-39. PubMed ID: 25627548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-quantitative structure-activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase.
    Lai Y; Yan Y; Liao S; Li Y; Ye Y; Liu N; Zhao F; Xu P
    Arch Pharm Res; 2020 May; 43(5):489-502. PubMed ID: 32248350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs.
    Dholakia D; Goyal S; Jamal S; Singh A; Das A; Grover A
    BMC Bioinformatics; 2016 Dec; 17(Suppl 19):512. PubMed ID: 28155702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.
    Chintakrindi AS; Martis EA; Gohil DJ; Kothari ST; Chowdhary AS; Coutinho EC; Kanyalkar MA
    Curr Comput Aided Drug Des; 2016; 12(4):272-281. PubMed ID: 27412704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of 4-alkyl-2-amino(acetamino)-6-aryl-1,3-thiazine derivatives as influenza neuraminidase inhibitors.
    Li W; Xia L; Hu A; Liu A; Peng J; Tan W
    Arch Pharm (Weinheim); 2013 Sep; 346(9):635-44. PubMed ID: 23926081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of crenatoside analogues as novel influenza neuraminidase inhibitors.
    Chen BL; Wang YJ; Guo H; Zeng GY
    Eur J Med Chem; 2016 Feb; 109():199-205. PubMed ID: 26774928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and bioassay of 4-thiazolinone derivatives as influenza neuraminidase inhibitors.
    Xiao M; Xu L; Lin D; Lian W; Cui M; Zhang M; Yan X; Li S; Zhao J; Ye J; Liu A; Hu A
    Eur J Med Chem; 2021 Mar; 213():113161. PubMed ID: 33540229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of novel zanamivir derivatives as potent neuraminidase inhibitors.
    Cheng LP; Wang TC; Yu R; Li M; Huang JW
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3622-3629. PubMed ID: 30389293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential New H1N1 Neuraminidase Inhibitors from Ferulic Acid and Vanillin: Molecular Modelling, Synthesis and in Vitro Assay.
    Hariono M; Abdullah N; Damodaran KV; Kamarulzaman EE; Mohamed N; Hassan SS; Shamsuddin S; Wahab HA
    Sci Rep; 2016 Dec; 6():38692. PubMed ID: 27995961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational design of drug candidates for influenza A virus subtype H1N1 by inhibiting the viral neuraminidase-1 enzyme.
    Tambunan US; Parikesit AA; Dephinto Y; Sipahutar FR
    Acta Pharm; 2014 Jun; 64(2):157-72. PubMed ID: 24914717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
    Singh A; Soliman ME
    Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata.
    Dao TT; Nguyen PH; Lee HS; Kim E; Park J; Lim SI; Oh WK
    Bioorg Med Chem Lett; 2011 Jan; 21(1):294-8. PubMed ID: 21123068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.